Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 8 Carcinoma, Non-Small-Cell Lung 7 Sarcoma 3 Thyroid Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Cancer Extensive Stage 1 Proteinuria 1 Platinum-resistant Ovarian Cancer (PROC) 1 Pheochromocytoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Melanoma 1 Limited Stage Small Cell Lung Cancer 1 Fallopian Tube Neoplasms 1 Extensive Stage Lung Small Cell Cancer 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 8 Carboplatin 7 Tirzepatide 3 Observation 3 Cisplatin 3 pembrolizumab 2 dostarlimab 2 Megestrol Acetate 2 Medroxyprogesterone Acetate 2 Blood Specimen Collection 2 trilaciclib 1 toripalimab 1 tislelizumab 1 sintilimab 1 semaglutide 1 olaparib 1 montelukast 1 inavolisib 1 enfortumab vedotin 1 ceralasertib 1 camrelizumab 1 apatinib 1 anlotinib 1 Watchful Waiting 1 Vaginal Smears 1 Topotecan 1 Tablets 1 Specimen Handling 1 Sensitivity Training Groups 1 Resistance Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Endometrial Neoplasms × anlotinib × Clear all

NCT05550558 2022-09-28

CAN-RESPOND

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡